InsiderTrades

Form 4 for INSM INSMED Inc

Accepted 2024-09-10 00:00:00 ET · period of report 2024-09-10 · accession 0001628280-24-040063 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-09-10 2024-09-10 INSM Schaeffer Orlov S Nicole Chief People Strategy Off M - OptEx $10.85 +37.6K 137.7K +38% +$407.7K
DM 2024-09-10 2024-09-10 INSM Schaeffer Orlov S Nicole Chief People Strategy Off S - Sale+OE $71.50 -37.6K 109.7K -26% -$2.69M
D 2024-09-10 2024-09-10 INSM Schaeffer Orlov S Nicole Chief People Strategy Off M - OptEx $0.00 -37.6K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-09-10 M A 37,575 $10.85 137,675 D — —
2 Common Common Stock 2024-09-10 S D 9,582 $71.88 100,100 D — — (F3) This is the weighted average sales price representing 9,582 shares sold at prices ranging from $71.80 to $72.06 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
3 Common Common Stock 2024-09-10 S D 27,993 $71.37 109,682 D — — (F2) This is the weighted average sales price representing 27,993 shares sold at prices ranging from $70.79 to $71.79 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
4 Derivative Stock Option (right to buy) 2024-09-10 M D 37,575 $0.00 0 D $10.85 · — to 2026-05-19 37,575 Common Stock (F4) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.